Skip Main Navigation
Page Content
This event has ended

Please visit the CONVERGE website for more info.

CONVERGE 2014

MedCity News

Tuesday, July 15, 2014 at 8:00 AM - Wednesday, July 16, 2014 at 12:00 PM

CONVERGE 2014

Ticket Information

Ticket Type Sales End Price Fee Quantity
ONSITE CONVERGE One Day July 15 Ended $600.00 $9.95
ONSITE CONVERGE One Day July 16 Ended $400.00 $9.95
ON-SITE CONVERGE July 15-16 Ended $850.00 $9.95

Share CONVERGE 2014

Event Details

MedCity CONVERGE provides the most accurate picture of the future of medical innovation by gathering decision-makers from every sector to debate the challenges and opportunities facing the industry. This national, executive-level summit gathers leaders from health systems, payers, medical device, pharma and digital health/health IT to join with entrepreneurs, government leaders, investors and other key stakeholders to see the latest innovations and create, through their conversations, truly actionable intelligence on where the innovation opportunities are right now.

Visit the CONVERGE event site for more information.

Have questions about CONVERGE 2014? Contact MedCity News
Attendee List Sort by: Date | First Name | Last Name
Show More

When & Where


Sheraton Philadelphia Downtown
201 North 17th Street
Philadelphia, PA 19103

Tuesday, July 15, 2014 at 8:00 AM - Wednesday, July 16, 2014 at 12:00 PM


  Add to my calendar

Organizer

MedCity News

MedCityNews.com is one of the fastest-growing sites in healthcare and life sciences. It is the leading destination covering the business of healthcare and life science innovation for decision makers in the healthcare industry. MedCity News offers insight into what’s next and what matters with a mix of breaking news and analysis on startups and established industry leaders, personalities, policies and the most important deals.


  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.